As of 2026-04-01, 广州白云山（广药集团）'s data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, below the industry average by 20.9 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 广州白云山（广药集团）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
广州白云山（广药集团）'s Mention Rate is 0.00%, lower than 0.6% of competitors
广州白云山（广药集团）'s First Mention is 0.00%, lower than 0.9% of competitors
广州白云山（广药集团）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
广州白云山（广药集团）'s Positive Rate is 0.00%, lower than 8.9% of competitors
广州白云山（广药集团）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 恒恒瑞医药 | 69.57% | 21.74% | 38.1% | 63.77% | 7.25% | View Details |
| 百百济神州 | 66.67% | 11.59% | 0% | 59.42% | 1.45% | View Details |
| 礼礼来 | 52.17% | 39.13% | 42.86% | 49.28% | 0% | View Details |
| 罗罗氏 | 40.58% | 1.45% | 4.76% | 34.78% | 1.45% | View Details |
| 中中国生物制药 | 39.13% | 0% | 0% | 28.99% | 0% | View Details |
| 诺诺和诺德 | 33.33% | 0% | 0% | 28.99% | 8.7% | View Details |
| 广广州白云山（广药集团） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
